Physician profile

Dawn Dickson Black

Obstetrics & Gynecology · Houston, TX

NPI 1710980909

$3,562.87

in general payments reported to CMS, 2019-2025

36 companies · $605 in 2025

The $605 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).

See the full distribution for Obstetrics & Gynecology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,493.89

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $578.51 2019-2023 Liletta, Orilissa, Lo Loestrin Fe
Exeltis, USA INC. $431.43 2020-2025 Slynd, Nuvessa, Tyblume
Astellas Pharma US INC $319.46 2019-2025 Veozah, Myrbetriq
Pfizer INC. $270.26 2019-2024
Hologic Sales and Service, LLC $178.69 2019-2025 Novasure, Myosure Tissue Removal Device, Fluent Fluid Management System
Medtronic, INC. $175.98 2023-2025 Venaseal, V-Loc 180
Exact Sciences Corporation $150.79 2023-2025 Cologuard Collection Kit
Coopersurgical, INC. $146.09 2019-2024 Advincula Delineator Uterine Manipulator
Agile Therapeutics, INC. $133.32 2021-2024 Twirla
Bayer Healthcare Pharmaceuticals INC. $121.20 2019-2023
Mayne Pharma Commercial LLC $118.63 2023
Myovant Sciences INC. $101.78 2021-2022
Medicem INC. $80.93 2020-2022
Organon LLC $79.96 2021-2022
Millicent US INC $78.78 2019-2020
Show all 34 companies
CompanyGeneral paymentsYearsTop products
Therapeuticsmd, INC. $61.50 2019-2022
Aspira Women'S Health INC $59.38 2022-2024 Ova1
Lupin INC. $55.57 2019-2020
Renovia INC $45.51 2019-2020
Merck Sharp & Dohme LLC $43.33 2019-2021
Supernus Pharmaceuticals, INC. $41.80 2025 Qelbree
Sage Therapeutics, LLC $41.80 2025 Zurzuvae
Allergan, INC. $34.20 2019-2020
Avion Pharmaceuticals $28.95 2020-2021
Smith+Nephew, INC. $28.59 2024 Pico 7
Evofem Biosciences, INC. $22.65 2024
Medline Industries LP $22.36 2024
Mylan Pharmaceuticals INC. $20.47 2020
Vertical Pharmaceuticals, LLC $19.14 2019
Novartis Pharmaceuticals Corporation $15.76 2019
Shield Therapeutics INC $15.63 2025
Sumitomo Pharma America, INC. $14.59 2023 Myfembree
Amgen INC. $13.98 2024 Prolia, Evenity
Scynexis, INC. $11.85 2022

2 companies reported research payments only; those appear in the research section below.

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Dawn Dickson Black

$3,562.87

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbvie INC.
Context
The $605 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).

https://glasscript.com/doctor/123576/dawn-dickson-black

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.